Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clinical trial of influenza virus split vaccine safety and immunogenicity
CTR20130457Phase 3Completed
- Sponsor
- Anhui Zhifei Longcom Biopharmaceutical
- Start
- Mar 2015
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of Quadrivalent influenza virus split vaccine (Zhifei Longcom) in influenza (2 arms), sponsored by Anhui Zhifei Longcom Biopharmaceutical. Started Mar 2015; status: completed.
02
Drugs
Quadrivalent influenza virus split vaccine (Zhifei Longcom)
03
Conditions
influenza
Beyond the preview
Go deeper on CTR20130457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20130457.